动态神经网络中的同步振荡

目前有一种假设认为同一视觉对象是由一群神经元的同步振荡活动来表征的。这一神经元发放活动的时间特性,是解决视觉信息处理中“结合问题（Ｂｉｎｄｉｎｇｐｒｏｂｌｅｍ）”的可能机制。本文用我们所提出的一种简化现实性神经网络模型［１］所构造的时滞非线性振子网络［２］,模拟生物神经网络的同步振荡活动。并考虑了振子各参数的设置与振荡活动的关系,以及网络振子间耦联对同步活动的影响．     

陕西乾县的旧石器

石制品八件,发现于陕西乾县大北沟黄土之下砂砾粘土层中,和更新世晚期的哺乳类化石伴存。另外由大北沟附近地表拾到一件手斧,和蓝田平梁的大尖状器相似,推测为旧石器时代的文化遗物。     

小麦×大麦胚胎发育的研究——Ⅰ.小麦×大麦胚和胚乳发育的观察

本试验以206小麦为母本,二棱大麦旱燕3号和六棱大麦原早1号为父本进进杂交。结果表明,两个组合早期的胚胎发育基本上是正常的,前者成胚率为8.75%,后者为16.8%。胚乳核最早于授粉后3天开始形成细胞。当胚乳细胞充满囊后,很快就转入迅速解体,胚随即停止生长,没有能够进一步分化出器官来。胚乳于授粉15天后,几乎全部败育,胚亦相继夭亡。胚胎发育过程中的不正常现象普遍存在。主要是极核受精过程遭受破坏;合子和初生胚乳核发育停滞;原胚虽能正常发育而胚乳没有形成;胚乳细胞过早形成和迅速解体等。讨论了杂交不孕和胚乳败育的原因。同时,提出了幼胚离体培养的适宜时间。     

走马胎的组织培养与快速繁殖

以走马胎(Ardisia gigantifolia)幼嫩茎段为外植体, 通过腋芽增殖的方式进行组织培养和快速繁殖研究。结果表明, 培养基MS+1.0 mg·L ^-1 6-BA+0.2 mg·L ^-1NAA和MS+0.5 mg·L ^-1 ZT均可用于腋芽的诱导和前期继代培养, 诱导率分别为89.3%和85.7%; 芽增殖最佳培养基为MS+0.5 mg·L ^-16-BA+0.1 mg·L ^-1ZT+0.1 mg·L ^-1NAA, 增殖系数为4.3倍; 根诱导最佳培养基为1/2MS+1.5 mg·L ^-1 IAA+1.0 mg·L ^-1 NAA, 生根率达92.3%, 且根系发达, 植株健壮; 生根苗在混合基质园土:泥炭:珍珠岩=3:1:1 (v/v/v )中移栽成活率为82%。该研究建立了走马胎种苗的组织培养快速繁殖技术体系, 且可应用于规模化生产。     

Adverse effects of cyclophosphamide on progeny outcome can be mediated through post-testicular mechanisms in the rat.

Previous studies from our laboratory have suggested that, in addition to an effect on spermatozoa in the testis, cyclophosphamide may have an adverse effect on spermatozoa after they leave the testis, during epididymal transit. To elaborate on this post-testicular effect on germ cells and to determine at which site(s) in the epididymis germ cells are most sensitive to cyclophosphamide treatment, three experiments were undertaken. First, the time course of the effect of treatment of male rats with cyclophosphamide on the outcome of their progeny was determined. Male rats were treated daily by gavage with saline or one of two doses of cyclophosphamide (6.8 mg/kg or 10.0 mg/kg) for 1, 4, or 7 days. At the end of each treatment period, males were mated to assess the effect on pregnancy outcome. No effect was observed on pre-implantation loss at any time among any of the groups, but there was a time-dependent and dose-related increase in post-implantation loss. Post-implantation loss was significantly increased after 4 days of treatment and reached nearly 40% after 7 days of drug exposure (10.0 mg/kg). Second, the effect of treatment with single high doses of cyclophosphamide was studied. Male rats were treated with a single dose of cyclophosphamide (10, 30, or 70 mg/kg) and bred 1 day and 4 days post-treatment. No significant change in pre-implantation loss was observed at either time point; no change in post-implantation loss was found after 1 day post-treatment. However, a significant increase in post-implantation loss was observed in the two high-dose groups 4 days post-treatment.(ABSTRACT TRUNCATED AT 250 WORDS)     

Population Differences in Brain Morphology and Microstructure among Chinese,Malay, and Indian Neonates

We studied a sample of 75 Chinese, 73 Malay, and 29 Indian healthy neonates taking part in a cohort study to examine potential differences in neonatal brain morphology and white matter microstructure as a function of ethnicity using both structural T2-weighted magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI). We first examined the differences in global size and morphology of the brain among the three groups. We then constructed the T2-weighted MRI and DTI atlases and employed voxel-based analysis to investigate ethnic differences in morphological shape of the brain from the T2-weighted MRI, and white matter microstructure measured by fractional anisotropy derived from DTI. Compared with Malay neonates, the brains of Indian neonates’ tended to be more elongated in anterior and posterior axis relative to the superior-inferior axis of the brain even though the total brain volume was similar among the three groups. Although most anatomical regions of the brain were similar among Chinese, Malay, and Indian neonates, there were anatomical variations in the spinal-cerebellar and cortical-striatal-thalamic neural circuits among the three populations. The population-related brain regions highlighted in our study are key anatomical substrates associated with sensorimotor functions.     

Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway

Bone loss (osteopenia) is a common complication in human solid tumour. In addition, after surgical treatment of gynaecological tumour, osteoporosis often occurs due to the withdrawal of oestrogen. The major characteristic of osteoporosis is the low bone mass with micro-architectural deteriorated bone tissue. And the main cause is the overactivation of osteoclastogenesis, which is one of the most important therapeutic targets. Inflammation could induce the interaction of RANKL/RANK, which is the promoter of osteoclastogenesis. Triptolide is derived from the traditional Chinese herb lei gong teng, presented multiple biological effects, including anti-cancer, anti-inflammation and immunosuppression. We hypothesized that triptolide could inhibits osteoclastogenesis by suppressing inflammation activation. In this study, we confirmed that triptolide could suppress RANKL-induced osteoclastogenesis in bone marrow mononuclear cells (BMMCs) and RAW264.7 cells and inhibited the osteoclast bone resorption functions. PI3K-AKT-NFATc1 pathway is one of the most important downstream pathways of RANKL-induced osteogenesis. The experiments in vitro indicated that triptolide suppresses the activation of PI3K-AKT-NFATc1 pathway and the target point located at the upstream of AKT because both NFATc1 overexpression and AKT phosphorylation could ameliorate the triptolide suppression effects. The expression of MDM2 was elevated, which demonstrated the MDM-p53-induced cell death might contribute to the osteoclastogenesis suppression. Ovariectomy-induced bone loss and inflammation activation were also found to be ameliorated in the experiments in vivo. In summary, the new effect of anti-cancer drug triptolide was demonstrated to be anti-osteoclastogenesis, and we demonstrated triptolide might be a promising therapy for bone loss caused by tumour.